课题基金 / 基金详情

Studies on causative gene defects in primary neutrophil abnormalities with a purpose of applying it to the gene therapy

Studies on causative gene defects in primary neutrophil abnormalities with a purpose of applying it to the gene therapy
原发性中性粒细胞异常致病基因缺陷的研究及其应用于基因治疗的目的
批准号:
06454299
负责人:
KOMIYAMA Atsushi
金额:
$3.78万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

KOMIYAMA Atsushi的其他基金

相关文献

中文摘要
翻译
本研究旨在分析中性粒细胞功能的诱导及其信号转导,确定原发性中性粒细胞异常的致病基因缺陷,以期将其应用于基因治疗。中性粒细胞功能的诱导及其信号转导分析(1)中性粒细胞功能是通过粘附分子CD11b诱导的,CD11b通过中性粒细胞与内皮细胞的相互作用来调节功能。(2)酪氨酸激酶被证明是fmlp诱导趋化的特异性信号通路。原发性中性粒细胞异常的致病基因缺陷分析(1)先天性中性粒细胞减少症(kostmann型):通过培养两例患者的骨髓细胞,可以获得足够用于本研究的中性粒细胞。G-CSF受体数量未减少,mRNA表达正常。(2)先天性中性粒细胞特异性颗粒缺乏:不仅防御蛋白mRNA表达缺失,乳铁蛋白、胶原酶mRNA表达也缺失或减少。使用几种限制性内切酶对这些基因组dna进行Southern blot分析未能显示异常条带。目前正在进行的研究是分析基因的侧翼区域和启动子。
英文摘要
The present studies were conducted to analyze the induction of neutrophil functions and its signal transduction and to determine the causative gene defects in primary neutrophil abnormalities with a purpose of applying it to the gene therapy.1. Analysis of induction of neutrophil functions and its signal transduction(1) Neutrophil functions were induced via CD11b, an adhesion molecule, which plays a role in regulating the functions by the interaction between neutrophils and endothelial cells.(2) The tyrosine kinase was demonstrated to be a specific signaling pathway for FMLP-induced chemotaxis.2. Analysis of causative gene defects in primary neutrophil abnormalities(1) Congenital neutropenia (kostmann type) : It was possible to get neutrophils enough to use for the present studies by culturing the bone marrow cells in two patients. The G-CSF receptor was not decreased in the number, and its mRNA expression was normal.(2) Congenital neutrophil-specific granule deficiency : There was no or reduced expression of mRNA for not only defensins but also lactoferrin and collagenase. Southern blot analysis of these genomic DNAs failed to demonstrate abnormal band by use of several restriction enzymes. Studies are now in progress to analyze the flanking regions and promoter of the genes.
期刊论文(74)
专著(0)
科研奖励(0)
会议论文
Yasui K.: "Pentoxiphyllin and CD14 antibody additively inhibit priming of PMN for enhanced release of superoxide・・." Infect. Immun.62. 922-927 (1994)
Yasui K.:“己酮毒素和 CD14 抗体可额外抑制 PMN 的启动,从而增强超氧化物的释放……”Infect.62。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yasui,K.: "Signal transduction pathway in human PMN for chemotaxis induced by a chemotactic factor." J.Immunol.152. 5922-5929 (1994)
Yasui,K.:“人中性粒细胞中趋化因子诱导趋化作用的信号转导途径。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
安井耕三: "新生児の好中球:機能と生理" 日本産婦人科・新生児血液学会雑誌. 5. 48-59 (1995)
Kozo Yasui:“新生儿中性粒细胞:功能和生理学”日本妇产科和新生儿血液学会杂志 5. 48-59 (1995)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
小宮山 淳: "血液病学" 三輪史朗他(編),文光堂, 1813 (1995)
Jun Komiyama:“血液学” Shiro Miwa 等(编辑),Bunkodo,1813(1995)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 25 条
    Analysis of primary immunodeficiency syndrome with low levels of antibody: diagnosis and treatment
    • 批准号:
      13470162
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.57万
    • 财政年份:
      2001
    • 负责人:
      KOMIYAMA Atsushi
    • 依托单位:
    Analysis of gene defects related to NK cell deficiency : Establishment of the disorder as a new immunodeficiency
    • 批准号:
      08457222
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $2.56万
    • 财政年份:
      1996
    • 负责人:
      KOMIYAMA Atsushi
    • 依托单位:
    Cytological analysis of and strategy for retarded nerve regeneration in aging animals
    • 批准号:
      05834012
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1993
    • 负责人:
      KOMIYAMA Atsushi
    • 依托单位:
    Establishment of hemopoietic cytokine therapy with a combination of hemopoietic factors for thrombocytopenia of childhood
    • 批准号:
      04454277
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $3.33万
    • 财政年份:
      1992
    • 负责人:
      KOMIYAMA Atsushi
    • 依托单位: